CELU CELULARITY INC Earnings Reports 8-K Filing 2024 - Revenue Expectations Celularity Inc. expects to report over $24 million in revenues from biomaterial products for the first half of 2024 and anticipates over $9 million from the recently acquired Rebound product, though these figures are preliminary and unaudited.Get access to all SEC 8-K filings of the CELULARITY INC